These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20143560)

  • 1. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
    Shvarts V
    Klin Med (Mosk); 2009; 87(11):17-24. PubMed ID: 20143560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial glucose regulation and diabetic complications.
    Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
    Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-prandial hyperglycaemia and vascular disease.
    Hanefeld M
    Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.
    Yamagishi S; Nakamura K; Takeuchi M; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(4):129-34. PubMed ID: 15754918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR
    Timely Top Med Cardiovasc Dis; 2008 Feb; 12():E3. PubMed ID: 18392213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of tissue damage in the postprandial state.
    Ceriello A
    Int J Clin Pract Suppl; 2001 Sep; (123):7-12. PubMed ID: 11594300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia.
    Lee IK; Kim HS; Bae JH
    Int J Clin Pract Suppl; 2002 Jul; (129):59-64. PubMed ID: 12166609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of blood glucose levels in the pathogenesis of (atherosclerotic) macroangiopathy].
    Simon K
    Orv Hetil; 2004 Apr; 145(16):861-6. PubMed ID: 15156691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.
    Haffner S
    Int J Clin Pract Suppl; 2001 Sep; (123):24-6. PubMed ID: 11594293
    [No Abstract]   [Full Text] [Related]  

  • 15. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
    Azuma K; Toyofuku Y; Iesaki T; Otsuka A; Tanaka A; Mita T; Hirose T; Tanaka Y; Daida H; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2006 Jun; 345(2):688-93. PubMed ID: 16696939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: counterpoint.
    Heine RJ
    Int J Clin Pract Suppl; 2001 Sep; (123):27-9. PubMed ID: 11594294
    [No Abstract]   [Full Text] [Related]  

  • 17. Postprandial hyperglycemia and hyperlipidemia-generated glycoxidative stress: its contribution to the pathogenesis of diabetes complications.
    Rebolledo OR; Actis Dato SM
    Eur Rev Med Pharmacol Sci; 2005; 9(4):191-208. PubMed ID: 16128039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrotyrosine: new findings as a marker of postprandial oxidative stress.
    Ceriello A
    Int J Clin Pract Suppl; 2002 Jul; (129):51-8. PubMed ID: 12166608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperglycemia and vascular damage role of oxidative stress].
    Esposito K; Giugliano D
    Recenti Prog Med; 2002 Mar; 93(3):172-4. PubMed ID: 11942168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.